National Institute of Neurological Disorders and Stroke NINDS intends to commit $2 million in FY 2021 to fund one award. March 15, 2021 Next Generation Sequencing in Post Mortem Tissue from Patients with Parkinsons Disease (U01 Clinical Trial Not Allowed) (RFA-NS-21-017)
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.